Rossari Biotech

Rossari Biotech EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Rossari Biotech (ROSSARI.NS) as of Oct 22, 2026 is 9.03 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 27.14 % — a change of -66.71% (lower).

EBIT/Assets

9.03 %

YoY

-66.71%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Rossari Biotech is 2026 9.03 % . Operating Income to Assets Ratio (EBIT/Assets) of Rossari Biotech was 2025 27.14 % . It decreases by -66.71% lower compared to the previous year.

The Rossari Biotech EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2019
26.27 INR
Jan 1, 2020
18.66 INR
Jan 1, 2021
19.27 INR
Jan 1, 2022
11.51 INR
Jan 1, 2023
11.33 INR
Jan 1, 2024
11.87 INR
Jan 1, 2025
27.14 INR
Jan 1, 2026
9.03 INR
The Rossari Biotech EBIT/Assets history
YEAREBIT/AssetsYoY
9.03 %-66.71%
27.14 %+128.68%
11.87 %+4.72%
11.33 %-1.56%
11.51 %-40.25%
19.27 %+3.29%
18.66 %-28.99%
26.27 %+15.35%
22.78 %+51.04%
15.08 %+99.69%
7.55 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Rossari Biotech Stock analysis

What does Rossari Biotech do? Rossari Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rossari Biotech stock

Operating Income to Assets Ratio (EBIT/Assets) of Rossari Biotech is 9.03 % in 2026.

Operating Income to Assets Ratio (EBIT/Assets) of Rossari Biotech changed from 27.14 % to 9.03 %, representing a -66.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Rossari Biotech since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Rossari Biotech with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Rossari Biotech

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Rossari Biotech